Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07376005

Effects of Acute Sugar Intake on Choroidal Thickness

This study aims to bridge that gap by investigating how acute sugar intake influences choroidal thickness.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Age range

21 year–35 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Southern College of Optometry

Memphis, Tennessee, 38111, United States

Location status: Recruiting

Location contact

Morgan Ollinger, OD, MS

CONTACT

[email protected]

9017223377

About this study

This investigation will be a prospective, repeated-measures study. All subjects will arrive fasted and will be asked not to consume any outside food or beverages during the three-hour study period, and will be asked to abstain from caffeine intake for 12 hours before participation. A baseline OCT scan of the macula of the right eye will be performed using the Heidelberg Spectralis OCT system. Participants will then consume 30 grams of sugar in the form of glucose tablets. Macular OCT scans of the right eye will be repeated every 30 minutes for 3 hours following sugar consumption.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • In order to be eligible for enrolment, each subject must have less than 6 diopters of spherical equivalent refractive error, and have no existing diagnosis of diabetes or pre-diabetes.

Exclusion criteria

  • Any potential subject with known retinal pathology will be excluded. Any potential subject with any other known systemic or ocular conditions that may impact their ability to participate in the study or provide generalizable data will also be excluded.

Treatment and study plan

Oral glucose

Dietary Supplement

Participants will consume 30 grams of sugar in the form of glucose tablets.

Primary outcomes

  1. Change in choroidal thickness

    Time frame: within 3 hours of baseline

    The primary outcome for this investigation will be changes in choroidal thickness from baseline across timepoints.

Study contacts

Contact information is provided by the study sponsor or research team.

Morgan Ollinger, OD, MS

CONTACT

[email protected]

9017223377

Sponsors and collaborators

Lead sponsor

Southern College of Optometry

Other

Registry information

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Jan 29, 2026
Registry last updated
Jan 29, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.